Theratechnologies Inc.

General ticker "THTX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $101.4M (TTM average)

Theratechnologies Inc. follows the US Stock Market performance with the rate: 35.0%.

Estimated limits based on current volatility of 0.3%: low 3.39$, high 3.41$

Factors to consider:

  • Earnings expected soon, date: 2025-10-09 bmo
  • Total employees count: 51 (-12.1%) as of 2024
  • Earnings for 6 months up through Q2 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-11-30 to 2026-11-30

  • 2024-11-30 to 2025-11-30 estimated range: [0.70$, 1.93$]
  • 2025-11-30 to 2026-11-30 estimated range: [0.97$, 2.38$]

Financial Metrics affecting the THTX estimates:

  • Negative: with PPE of -11.0 at the end of fiscal year the price was high
  • Negative: Shareholder equity ratio, % of -47.38 <= 19.77
  • Positive: 7.90 < Operating profit margin, % of 9.52
  • Positive: Investing cash flow per share per price, % of 1.58 > -0.75
  • Positive: 0.85 < Operating cash flow per share per price, % of 3.99
  • Positive: Inventory ratio change, % of -1.11 <= -0.84
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: negative Net income

Similar symbols

Short-term THTX quotes

Long-term THTX plot with estimates

Financial data

YTD 2022-11-30 2023-11-30 2024-11-30
Operating Revenue $80.06MM $81.76MM $85.87MM
Operating Expenses $119.97MM $92.39MM $77.69MM
Operating Income $-39.91MM $-10.63MM $8.17MM
Non-Operating Income $-6.89MM $-12.91MM $-14.47MM
Interest Expense $6.50MM $10.55MM $10.42MM
R&D Expense $36.94MM $30.37MM $16.97MM
Income(Loss) $-46.79MM $-23.54MM $-6.30MM
Taxes $0.44MM $0.42MM $2.00MM
Profit(Loss)* $-47.24MM $-23.96MM $-8.31MM
Stockholders Equity $-22.57MM $-20.87MM $-25.27MM
Inventory $19.69MM $6.07MM $5.28MM
Assets $93.26MM $77.77MM $53.34MM
Operating Cash Flow $-14.69MM $-5.68MM $2.38MM
Capital expenditure $0.98MM $1.82MM $1.50MM
Investing Cash Flow $8.68MM $1.11MM $0.94MM
Financing Cash Flow $9.66MM $14.78MM $-21.49MM
Earnings Per Share** $-0.50 $-0.33 $-0.17

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.